相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A survey of psoriasis patients on biologics during COVID-19: a single centre experience
Martina Burlando et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study
Ilteris Oguz Topal et al.
JOURNAL OF COSMETIC DERMATOLOGY (2022)
The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey
Selda Pelin Kartal et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
Vartan Pahalyants et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
Brian MacKenna et al.
LANCET RHEUMATOLOGY (2022)
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis
Shintaro Akiyama et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study
Satveer K. Mahil et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey
S. K. Mahil et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul
Asude Kara Polat et al.
DERMATOLOGIC THERAPY (2021)
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II
Elisa Camela et al.
DERMATOLOGY (2021)
Psoriasis: Recent progress in molecular-targeted therapies
Masaru Honma et al.
JOURNAL OF DERMATOLOGY (2021)
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments
Joel M. Gelfand et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
A systematic review of the prevalence of anxiety among the general population during the COVID-19 pandemic
Fatemeh Pashazadeh Kan et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Anja Strangfeld et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
Damian F. Santomauro et al.
LANCET (2021)
Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD
John Sperger et al.
BMJ OPEN (2021)
Psoriasis: a brief overview
Antony Raharja et al.
CLINICAL MEDICINE (2021)
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
Zara Izadi et al.
JAMA NETWORK OPEN (2021)
Biologics for Psoriasis during the COVID-19 Pandemic
Koji Kamiya et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study
S. K. Mahil et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course
Basak Yalici-Armagan et al.
JOURNAL OF COSMETIC DERMATOLOGY (2021)
COVID-19 and psoriasis: Should we fear for patients treated with biologics?
Paolo Amerio et al.
DERMATOLOGIC THERAPY (2020)
Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece
E. Vakirlis et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic
F. Rob et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis
Nader Salari et al.
GLOBALIZATION AND HEALTH (2020)
Nonadherence to Treatment and Patient-Reported Outcomes of Psoriasis During the COVID-19 Epidemic: A Web-Based Survey
Qiaolin Wang et al.
PATIENT PREFERENCE AND ADHERENCE (2020)
Impact of COVID-19 pandemic on mental health in the general population: A systematic review
Jiaqi Xiong et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients' Medication Beliefs and Habit Strength
Rachael J. Thorneloe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis
R. J. Thorneloe et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry
Paula Davila-Seijo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases
Eleni Vangeli et al.
ADVANCES IN THERAPY (2015)
Self-report measures of medication adherence behavior: recommendations on optimal use
Michael J. Stirratt et al.
TRANSLATIONAL BEHAVIORAL MEDICINE (2015)
Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities
Sue Ann Chan et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2013)
The influence of symptoms of anxiety and depression on medication nonadherence and its causes: a population based survey of prescription drug users in Sweden
Lena Thunander Sundbom et al.
PATIENT PREFERENCE AND ADHERENCE (2013)
Depression and Medication Adherence in the Treatment of Chronic Diseases in the United States: A Meta-Analysis
Jerry L. Grenard et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Physician Communication and Patient Adherence to Treatment
Kelly B. Haskard Zolnierek et al.
MEDICAL CARE (2009)
Anxiety disorders in primary care:: Prevalence, impairment, comorbidity, and detection
Kurt Kroenke et al.
ANNALS OF INTERNAL MEDICINE (2007)
The Patient Health Questionnaire-2 - Validity of a two-item depression screener
K Kroenke et al.
MEDICAL CARE (2003)
Depression is a risk factor for noncompliance with medical treatment -: Meta-analysis of the effects of anxiety and depression on patient adherence
MR DiMatteo et al.
ARCHIVES OF INTERNAL MEDICINE (2000)